Skeletal Dysplasia Account Manager - Washington, D.C.

Role: Skeletal Dysplasia Account Manager driving the launch of Infigratinib for achondroplasia, focusing on community engagement and sales growth. Responsibilities: develop territory business plans targeting specialists (geneticists, pediatric endocrinologists, orthopedic surgeons), build clinical expertise, identify growth opportunities, and collaborate with cross-functional teams including Medical and Marketing. Requirements: 8–10 years pharma/biotech experience, 4+ years in rare or genetic diseases, BS/BA (MBA preferred), strong account management, and proven product launch success; willingness to travel extensively. HighValue: rare pediatric genetic disorder (achondroplasia), first-in-class therapy, launch phase, targeted healthcare providers, multi-territory coverage in Northeast US, and customer-focused clinical engagement. WorkSetup: Northeast US territories, hybrid model with extensive travel.